The 3-year disease-free survival rate was 86.4% in the atezolizumab arm and 76.6% in the control arm. Adding atezolizumab to adjuvant treatment with mFOLFOX6 (folinic acid, fluorouracil, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback